LSD Clinical Trials
34 record(s) found.
Entheogen: lysergic acid diethylamideStudy Title: Minidosing Lysergic Acid Diethylamide (LSD) for Chronic Cluster HeadacheStart Date: May 01, 2023 - Last Update: August 1, 2022Conditions: Chronic Cluster HeadacheLocation(s): Source: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming IndividualsStart Date: Jan 01, 2023 - Last Update: July 26, 2022Conditions: Methamphetamine Abuse, Methamphetamine-dependenceLocation(s): CanadaSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: LSD Treatment for Persons With Alcohol Use DisorderStart Date: Jan 01, 2023 - Last Update: July 26, 2022Conditions: Alcohol Use Disorder (AUD)Location(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy SubjectsStart Date: Mar 17, 2022 - Last Update: March 31, 2022Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Effects of SERT Inhibition on the Subjective Response to LSD in Healthy SubjectsStart Date: Mar 01, 2022 - Last Update: January 3, 2022Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Effects of LSD on Neuroplasticity in Healthy SubjectsStart Date: Feb 01, 2022 - Last Update: January 4, 2022Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Safety and Efficacy of Low Dose MM-120 for ADHD Proof of Concept TrialStart Date: Dec 17, 2021 - Last Update: June 21, 2022Conditions: ADHD, Attention Deficit DisorderLocation(s): Netherlands, SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Safety and efficacy of repeated low dose D-lysergic acid diethylamide (LSD) D-Tartrate (MM-120) as treatment for ADHD in adults: a multi-center, randomized, double- blind, placebo-controlled Phase ...
Start Date: Nov 24, 2021Conditions: Attention-Deficit/Hyperactivity Disorder
Location(s): NetherlandsSource: www.clinicaltrialsregister.eushort summary
Entheogen: lysergic acid diethylamideStudy Title: Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of ConsciousnessStart Date: Aug 11, 2021 - Last Update: August 18, 2021Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: A randomised, double-blind, placebo-controlled trial of repeated microdoses of lysergic acid diethylamide (LSD) in healthy volunteersStart Date: Jan 05, 2021Conditions: Major depressive disorderLocation(s): New ZealandSource: anzctr.org.aushort summary
Entheogen: lysergic acid diethylamideStudy Title: Effects of MDMA Co-administration on the Response to LSD in Healthy SubjectsStart Date: Jan 01, 2021 - Last Update: September 8, 2021Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Effect of Ketanserin After LSD AdministrationStart Date: Oct 16, 2020 - Last Update: October 21, 2021Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: The Canadian Underage Substance Use Prevention TrialStart Date: Dec 01, 2019 - Last Update: December 17, 2019Conditions: Substance Use Disorders, Adolescent Behavior, Adolescent DevelopmentLocation(s): CanadaSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: LSD Therapy for Persons Suffering From Major DepressionStart Date: Nov 01, 2019 - Last Update: May 25, 2022Conditions: Major Depressive DisorderLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Dosing Intervals of Opioid Medication for Chronic PainStart Date: May 01, 2019 - Last Update: March 27, 2020Conditions: Chronic PainLocation(s): CanadaSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Direct Comparison of Altered States of Consciousness Induced by LSD and PsilocybinStart Date: Mar 27, 2019 - Last Update: April 27, 2021Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Lysergic Acid Diethylamide (LSD) as Treatment for Cluster HeadacheStart Date: Jan 02, 2019 - Last Update: May 5, 2022Conditions: Cluster HeadacheLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Prevalence of New Psychoactive Substances UseStart Date: Jan 01, 2019 - Last Update: October 5, 2018Conditions: AddictionLocation(s): Source: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Mood Effects of Serotonin AgonistsStart Date: May 01, 2018 - Last Update: December 31, 2018Conditions: HealthyLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study)Start Date: Nov 28, 2017 - Last Update: August 28, 2019Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety DisordersStart Date: Jun 23, 2017 - Last Update: December 22, 2021Conditions: Patients, Anxiety DisordersLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Differential Responses to Drugs and Sweet TastesStart Date: Feb 09, 2017 - Last Update: January 22, 2019Conditions: Bipolar II DisorderLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion ProcessingStart Date: Feb 01, 2017 - Last Update: October 15, 2018Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 YearsStart Date: Jun 29, 2015 - Last Update: June 9, 2020Conditions: Healthy VolunteersLocation(s): Source: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy VolunteersStart Date: Mar 01, 2015 - Last Update: February 1, 2016Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Neuronal Correlates of Altered States of ConsciousnessStart Date: Dec 01, 2014 - Last Update: September 25, 2015Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Pilot Study of Entacapone for Methamphetamine AbuseStart Date: Jun 01, 2014 - Last Update: September 12, 2019Conditions: Methamphetamine DependenceLocation(s): United StatesSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled StudyStart Date: Jun 01, 2013 - Last Update: January 21, 2016Conditions: HealthyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid UsersStart Date: Mar 01, 2012 - Last Update: November 21, 2012Conditions: Drug AbuseLocation(s): United States, CanadaSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug UsersStart Date: Oct 01, 2009 - Last Update: April 2, 2013Conditions: Alzheimer's Disease, Huntington's DiseaseLocation(s): Source: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug UsersStart Date: Sep 01, 2009 - Last Update: February 12, 2016Conditions: Abuse Potential StudyLocation(s): Source: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Abuse Potential of SativexStart Date: Feb 01, 2008 - Last Update: June 14, 2013Conditions: Evaluation of Abuse Potential of SativexLocation(s): CanadaSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related AnxietyStart Date: Feb 01, 2008 - Last Update: July 6, 2022Conditions: AnxietyLocation(s): SwitzerlandSource: clinicaltrials.govshort summary
Entheogen: lysergic acid diethylamideStudy Title: A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure Which Aims to Evaluate Whether GRT0151Y is Likely to be AbusedStart Date: Jun 21, 2007 - Last Update: December 7, 2018Conditions: Pain, Acute PainLocation(s): CanadaSource: clinicaltrials.govshort summary
Total execution time in seconds: 0.019841909408569